Literature DB >> 25741011

Diversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in Humans.

Alexandra J Lee1, Suman R Das2, Wei Wang2, Theresa Fitzgerald3, Brett E Pickett1, Brian D Aevermann1, David J Topham3, Ann R Falsey3, Richard H Scheuermann4.   

Abstract

UNLABELLED: Although a large number of immune epitopes have been identified in the influenza A virus (IAV) hemagglutinin (HA) protein using various experimental systems, it is unclear which are involved in protective immunity to natural infection in humans. We developed a data mining approach analyzing natural H1N1 human isolates to identify HA protein regions that may be targeted by the human immune system and can predict the evolution of IAV. We identified 16 amino acid sites experiencing diversifying selection during the evolution of prepandemic seasonal H1N1 strains and found that 11 sites were located in experimentally determined B-cell/antibody (Ab) epitopes, including three distinct neutralizing Caton epitopes: Sa, Sb, and Ca2 [A. J. Caton, G. G. Brownlee, J. W. Yewdell, and W. Gerhard, Cell 31:417-427, 1982, http://dx.doi.org/10.1016/0092-8674(82)90135-0]. We predicted that these diversified epitope regions would be the targets of mutation as the 2009 H1N1 pandemic (pH1N1) lineage evolves in response to the development of population-level protective immunity in humans. Using a chi-squared goodness-of-fit test, we identified 10 amino acid sites that significantly differed between the pH1N1 isolates and isolates from the recent 2012-2013 and 2013-2014 influenza seasons. Three of these sites were located in the same diversified B-cell/Ab epitope regions as identified in the analysis of prepandemic sequences, including Sa and Sb. As predicted, hemagglutination inhibition (HI) assays using human sera from subjects vaccinated with the initial pH1N1 isolate demonstrated reduced reactivity against 2013-2014 isolates. Taken together, these results suggest that diversifying selection analysis can identify key immune epitopes responsible for protective immunity to influenza virus in humans and thereby predict virus evolution. IMPORTANCE: The WHO estimates that approximately 5 to 10% of adults and 20 to 30% of children in the world are infected by influenza virus each year. While an adaptive immune response helps eliminate the virus following acute infection, the virus rapidly evolves to evade the established protective memory immune response, thus allowing for the regular seasonal cycles of influenza virus infection. The analytical approach described here, which combines an analysis of diversifying selection with an integration of immune epitope data, has allowed us to identify antigenic regions that contribute to protective immunity and are therefore the key targets of immune evasion by the virus. This information can be used to determine when sequence variations in seasonal influenza virus strains have affected regions responsible for protective immunity in order to decide when new vaccine formulations are warranted.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25741011      PMCID: PMC4442545          DOI: 10.1128/JVI.03636-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees.

Authors:  A Stamatakis; T Ludwig; H Meier
Journal:  Bioinformatics       Date:  2004-12-17       Impact factor: 6.937

2.  HyPhy: hypothesis testing using phylogenies.

Authors:  Sergei L Kosakovsky Pond; Simon D W Frost; Spencer V Muse
Journal:  Bioinformatics       Date:  2004-10-27       Impact factor: 6.937

Review 3.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

4.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

5.  The glycosylation of the influenza A virus hemagglutinin by mammalian cells. A site-specific study.

Authors:  S Y Mir-Shekari; D A Ashford; D J Harvey; R A Dwek; I T Schulze
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

6.  Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift.

Authors:  Scott E Hensley; Suman R Das; Adam L Bailey; Loren M Schmidt; Heather D Hickman; Akila Jayaraman; Karthik Viswanathan; Rahul Raman; Ram Sasisekharan; Jack R Bennink; Jonathan W Yewdell
Journal:  Science       Date:  2009-10-30       Impact factor: 47.728

7.  Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses.

Authors:  Bin Zhou; Matthew E Donnelly; Derek T Scholes; Kirsten St George; Masato Hatta; Yoshihiro Kawaoka; David E Wentworth
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

8.  Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins.

Authors:  Nicholas S Heaton; David Sachs; Chi-Jene Chen; Rong Hai; Peter Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

9.  The immune epitope database 2.0.

Authors:  Randi Vita; Laura Zarebski; Jason A Greenbaum; Hussein Emami; Ilka Hoof; Nima Salimi; Rohini Damle; Alessandro Sette; Bjoern Peters
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971

10.  Evolutionary trends of A(H1N1) influenza virus hemagglutinin since 1918.

Authors:  Jun Shen; Jianpeng Ma; Qinghua Wang
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more
  11 in total

1.  Clinical Performance of the AllplexTM Respiratory Panel 1 Test Compared to SimplexaTM Flu A/B and RSV for Detection of Influenza Virus and Respiratory Syncytial Virus Infection Including Their Subtyping.

Authors:  Jeeyong Kim; Jeonghun Nam; Woongsik Jang; Chae Seung Lim
Journal:  Med Princ Pract       Date:  2019-03-04       Impact factor: 1.927

2.  Temporal distribution and genetic variants in influenza A(H1N1)pdm09 virus circulating in Mexico, seasons 2012 and 2013.

Authors:  Jose Reyes Canche-Pech; Laura Conde-Ferraez; Marylin Puerto-Solis; Refugio Gonzalez-Losa; Pilar Granja-Pérez; Salha Villanueva-Jorge; Maria Chan-Gasca; Jesus Gómez-Carballo; Luisa López-Ochoa; Bertha Jiménez-Delgadillo; Iram Rodríguez-Sánchez; Jorge Ramírez-Prado; Guadalupe Ayora-Talavera
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

3.  Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.

Authors:  Amelia M Clark; Marta L DeDiego; Christopher S Anderson; Jiong Wang; Hongmei Yang; Aitor Nogales; Luis Martinez-Sobrido; Martin S Zand; Mark Y Sangster; David J Topham
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

4.  Antigenic cartography of H1N1 influenza viruses using sequence-based antigenic distance calculation.

Authors:  Christopher S Anderson; Patrick R McCall; Harry A Stern; Hongmei Yang; David J Topham
Journal:  BMC Bioinformatics       Date:  2018-02-12       Impact factor: 3.169

5.  Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019.

Authors:  Danuta M Skowronski; Siobhan Leir; Suzana Sabaiduc; Michelle Murti; James A Dickinson; Romy Olsha; Jonathan B Gubbay; Matthew A Croxen; Hugues Charest; Tracy Chan; Nathalie Bastien; Yan Li; Mel Krajden; Gaston De Serres
Journal:  Euro Surveill       Date:  2019-01

6.  Prediction model for the spread of the COVID-19 outbreak in the global environment.

Authors:  Ron S Hirschprung; Chen Hajaj
Journal:  Heliyon       Date:  2021-06-29

7.  Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection.

Authors:  Yvonne C F Su; Justin Bahl; Udayan Joseph; Ka Man Butt; Heidi A Peck; Evelyn S C Koay; Lynette L E Oon; Ian G Barr; Dhanasekaran Vijaykrishna; Gavin J D Smith
Journal:  Nat Commun       Date:  2015-08-06       Impact factor: 14.919

8.  Genome-Wide Analysis of Evolutionary Markers of Human Influenza A(H1N1)pdm09 and A(H3N2) Viruses May Guide Selection of Vaccine Strain Candidates.

Authors:  Sergei S Belanov; Dmitrii Bychkov; Christian Benner; Samuli Ripatti; Teija Ojala; Matti Kankainen; Hong Kai Lee; Julian Wei-Tze Tang; Denis E Kainov
Journal:  Genome Biol Evol       Date:  2015-11-27       Impact factor: 3.416

9.  Applying Unique Molecular Identifiers in Next Generation Sequencing Reveals a Constrained Viral Quasispecies Evolution under Cross-Reactive Antibody Pressure Targeting Long Alpha Helix of Hemagglutinin.

Authors:  Nastasja C Hauck; Josiane Kirpach; Christina Kiefer; Sophie Farinelle; Sophie Maucourant; Stephen A Morris; William Rosenberg; Feng Q He; Claude P Muller; I-Na Lu
Journal:  Viruses       Date:  2018-03-25       Impact factor: 5.048

10.  The influenza virus hemagglutinin head evolves faster than the stalk domain.

Authors:  Ericka Kirkpatrick; Xueting Qiu; Patrick C Wilson; Justin Bahl; Florian Krammer
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.